📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial. (2017)

First Author: Abbara A

Attributed to: MICA: Neurokinin 3 Receptor Antagonism as a Novel Treatment for Menopausal Hot Flushes funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/humrep/dex253

PubMed Identifier: 28854728

Publication URI: http://europepmc.org/abstract/MED/28854728

Type: Journal Article/Review

Volume: 32

Parent Publication: Human reproduction (Oxford, England)

Issue: 9

ISSN: 0268-1161